1PXZ
| 1.7 Angstrom Crystal Structure of jun a 1, the major allergen from cedar pollen | Descriptor: | Major pollen allergen Jun a 1 | Authors: | Czerwinski, E.W, White, M.A, Midoro-Horiuti, T, Brooks, E.G, Goldblum, R.M. | Deposit date: | 2003-07-07 | Release date: | 2004-11-16 | Last modified: | 2017-10-11 | Method: | X-RAY DIFFRACTION (1.7 Å) | Cite: | Crystal structure of Jun a 1, the major cedar pollen allergen from Juniperus ashei, reveals a parallel beta-helical core. J.Biol.Chem., 280, 2005
|
|
7DF8
| full length hNPC1L1-Apo | Descriptor: | 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, ... | Authors: | Hu, M, Sun, S, Sui, S. | Deposit date: | 2020-11-06 | Release date: | 2021-08-04 | Method: | ELECTRON MICROSCOPY (3.03 Å) | Cite: | Structural insights into the mechanism of human NPC1L1-mediated cholesterol uptake. Sci Adv, 7, 2021
|
|
7DFW
| Cryo_EM structure of delta N-NPC1L1-CLR | Descriptor: | 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-3)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, ... | Authors: | Hu, M, Sun, S. | Deposit date: | 2020-11-10 | Release date: | 2021-08-11 | Method: | ELECTRON MICROSCOPY (2.69 Å) | Cite: | Structural insights into the mechanism of human NPC1L1-mediated cholesterol uptake. Sci Adv, 7, 2021
|
|
7DFZ
| Cryo_EM structure of delta N-NPC1L1-EZE | Descriptor: | (3~{R},4~{S})-1-(4-fluorophenyl)-3-[(3~{S})-3-(4-fluorophenyl)-3-oxidanyl-propyl]-4-(4-hydroxyphenyl)azetidin-2-one, 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-3)-2-acetamido-2-deoxy-beta-D-glucopyranose, ... | Authors: | Hu, M, Sun, S. | Deposit date: | 2020-11-10 | Release date: | 2021-08-11 | Method: | ELECTRON MICROSCOPY (3.58 Å) | Cite: | Structural insights into the mechanism of human NPC1L1-mediated cholesterol uptake. Sci Adv, 7, 2021
|
|
7EO6
| X-ray structure analysis of xylanase | Descriptor: | Endo-1,4-beta-xylanase, IODIDE ION | Authors: | Wan, Q, Yi, Y, Xu, S. | Deposit date: | 2021-04-21 | Release date: | 2021-10-13 | Last modified: | 2023-11-29 | Method: | X-RAY DIFFRACTION (1.9 Å) | Cite: | Characterization and structural analysis of a thermophilic GH11 xylanase from compost metatranscriptome. Appl.Microbiol.Biotechnol., 105, 2021
|
|
7EO3
| X-ray structure analysis of beita-1,3-glucanase | Descriptor: | 1,3-beta-glucanase, 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL, MAGNESIUM ION | Authors: | Wan, Q, Feng, J, Xu, S. | Deposit date: | 2021-04-21 | Release date: | 2022-03-02 | Last modified: | 2023-11-29 | Method: | X-RAY DIFFRACTION (1.141 Å) | Cite: | Identification and structural analysis of a thermophilic beta-1,3-glucanase from compost Bioresour Bioprocess, 8, 2021
|
|
7X9Q
| Crystal structure of human STING complexed with compound BSP16 | Descriptor: | (2R)-4-(5,6-dimethoxy-1-benzoselenophen-2-yl)-2-ethyl-4-oxidanylidene-butanoic acid, Stimulator of interferon genes protein | Authors: | Pan, L, Guan, X, Feng, X, Li, Z, Bian, J. | Deposit date: | 2022-03-15 | Release date: | 2022-09-28 | Last modified: | 2023-11-29 | Method: | X-RAY DIFFRACTION (2.4 Å) | Cite: | Discovery of Selenium-Containing STING Agonists as Orally Available Antitumor Agents. J.Med.Chem., 65, 2022
|
|
7X9P
| Crystal structure of human STING complexed with compound BSP17 | Descriptor: | 4-[6-methoxy-5-[3-[[6-methoxy-2-(4-oxidanyl-4-oxidanylidene-butanoyl)-1-benzoselenophen-5-yl]oxy]propoxy]-1-benzoselenophen-2-yl]-4-oxidanylidene-butanoic acid, Stimulator of interferon genes protein | Authors: | Pan, L, Guan, X, Feng, X, Li, Z, Bian, J. | Deposit date: | 2022-03-15 | Release date: | 2023-03-22 | Last modified: | 2023-11-29 | Method: | X-RAY DIFFRACTION (2.7 Å) | Cite: | Discovery of Selenium-containing STING agonists as orally available anti tumor agents To be published
|
|